Market Research Industry Today

AI In Genomics Market

AI In Genomics Market was valued USD 500 Billion in 2022 and projected to reach USD 5615.03 Billion by 2030, growing at a CAGR of 35.3% during the forecast period of 2023-2030 - published by MarketDigits
Published 14 November 2024

According to a research report "AI In Genomics Market, by Component (Software, Hardware, Services), Technology (Machine Learning {Deep Learning, Supervised Learning, Reinforcement Learning, Unsupervised Learning}, Others), Functionality (Genome Sequencing, Gene Editing, Clinical Workflows, Predictive Genetic Testing & Preventive Medicine), Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Agriculture & animal Research, Others), End-Use (Pharmaceutical & Biotech Companies , Government Organizations, Healthcare Providers, Others), & Region - Global Forecast to 2030".

Download the Sample - https://www.marketdigits.com/request/sample/1062

  • 148 - Market Data Tables 
  • 72 - List of Figures
  • 278 - Pages

Market Overview: AI, an intelligent system, applies human-like reasoning, learning, and problem-solving in fields like healthcare, computer science, math, and engineering. Its integration in healthcare automates tasks, analyzes patient data, and enhances care efficiency and cost-effectiveness, aiding disease diagnosis and gene variation identification. In genomics, AI encompasses on-premises, cloud, and web-based software and services. It's pivotal in genome sequencing, editing, pharmacogenomics, and gene testing, speeding drug discovery, precision medicine, diagnostics, and more. Growth drivers include cost control, increased AI investments, and precision medicine adoption. Collaboration, investments, and improved computing power also contribute to market expansion, alongside the burgeoning bioinformatics and genomic data.

Market Dynamics

Drivers:

  • The Adoption Of AI In Precision Medicine Is On The Rise.
  • AI Is Increasingly Applied In Genomics, Accompanied By A Surge In Genomics Investment.
  • AI In Genomics Are Reduce The Cost Of Sequencing

Opportunities:

  • Increased Funding And Investment.
  • Increasing Advancements In Drug Discovery.

The AI In Genomics Market is dominated by North America.

The AI in genomics market is predominantly dominated by North America due to a combination of factors. The region boasts a robust infrastructure for genomics research and development, a high level of investment in AI technologies, and a well-established healthcare system. Additionally, North America houses a concentration of leading AI and genomics companies, research institutions, and academic centers. The presence of a well-defined regulatory framework and supportive policies for AI and genomics applications further strengthens its market dominance. The region's leadership in genomics research, combined with significant public and private investments, positions North America at the forefront of the AI in genomics market, driving innovation and adoption of these technologies.

Key Players covered in the market report:

  • IBM
  • Microsoft
  • NVIDIA
  • Deep Genomics
  • DATA4CURE
  • Freenome holdings, Inc
  • Thermo fisher scientific
  • Illumina Inc
  • Sophia Genetics
  • BenevolentA
  • verge genomics
  • Molecular match Inc
  • Tempus
  • Fabric Genomics
  • Congenica Ltd
  • BGI Genomics
  • QIAGEN
  • Seven Bridges Genomics
  • PierianDx
  • DNAnexus Inc

Direct Buy this report @ https://www.marketdigits.com/checkout/1062

Segmentations Analysis of AI In Genomics Market: -

  • By Component
  • By Technology
  • By Functionality
  • By Application
  • By End-Use
  • By Region

Recent Development: In June 2022, Ultima Genomics Collaborates with NVIDIA To Deliver $100 Genome Sequencing with AI and Accelerated Computing. Ultima Genomics, Inc. today unveiled a broad collaboration with NVIDIA that leverages AI-accelerated analysis across multiple stages of the DNA sequencing and analysis process. The collaboration includes the use of NVIDIA GPUs for deep learning in photometry and base calling and will soon include acceleration of variant calling.

About us:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

Contact Us: Email: sales@marketdigits.com

Other Industry News

Ready to start publishing

Sign Up today!